While studying at Oxford University, he made a major discovery in the laboratory and decided to leave neurosurgery training to develop the findings into a new drug.
After over 6 months without traction, he returned to academia to carry out the research. This meant the university now owned his invention and it took 27 months to license back his own technology, nearly killing the young startup.
Never able to land marquis VC funding, Dr. Carbonell essentially bootstrapped the company one angel investor financing at a time.
Through determination, hard work, a great team, and a lot of luck... Dr. Carbonell eventually raised over $20M for his startup. The cancer drug he invented from a mere idea—OS2966—is now in a human phase 1 clinical trial at Moffitt Cancer Center in Tampa, FL!
Our thesis is there is massive unlocked value in scientists—like Dr. Carbonell—bringing their own research to patients through startups. We are recruiting a Brazen Army to take on the establishment. Will you invest and join us?
The Brazen Fellowship is the only biotech accelerator headed by an entrepreneur who has actually lived the biotech startup journey from idea to patient.
Cofounders Dr. Shawn Carbonell and Dr. Brent Witgen have been friends for over 20 years. Our newest team member is Rachel Strohmeyer, Senior Marketing Strategist. She comes to us via marketing and sales roles at biotech companies Quantgene and Invitae.
Based in Los Angeles, California, the Brazen Fellowship is the only in-person biotech startup accelerator of its kind.
Brazen Fellows are provided everything Dr. Carbonell would have wanted when he started including: funding, laboratory access, coliving at Brazen House, weekly founder dinners, weekly office hours, events/networking, access to advisors, and more.
Brazen Bio is rapidly building a diverse, worldwide network of advisors with broad expertise in biopharma, innovation, and beyond.
The founding Brazen Bio Advisory Board is represented by legendary life sciences intellectual property attorney, Lisa Haile, JD, PhD—who has the unique distinction of having done patent work for NINE Nobel laureates—and John Boockvar, MD the Vice-Chairman of Neurosurgery at Lenox Hill Hospital (NYC) and Main Character of the award-nominated docuseries "Lenox Hill" on Netflix.
Brazen Bio is independent of the "big establishment" players in academia, industry, or venture capital. This enables us to be "founder friendly first"—completely aligned with the success of Brazen Fellows. Our unique ecosystem revolves around reducing the frictions of being a biotech founder and Brazen Fellows can count on continued support beyond the completion of the program.
Brazen Fellows are provided state-of-the-art laboratory access at BioLabs LA. This purpose-built facility opened in 2019 and is the anchor to what will become a multi-billion dollar biotech hub adjacent to Harbor-UCLA Hospital. Brazen Fellows will enjoy free access to over $2M in new laboratory equipment and technologies and to core resources in the Lundquist/UCLA network.
Brazen House is the world's first ever biotech launch house located in beautiful Redondo Beach, California. As well as providing accommodation for Brazen Fellows and guests, it is the site of many Brazen Events big and small including founder/investor happy hours, salons, and dinner parties.Take a 20-second tour of Brazen House on TikTok!
Brazen Bio launched May 2021 with the Brazen Fellowship and ended the year with the founding of Brazen Capital, our venture capital partner (see below). In 2022, we will focus on building another differentiated product—Brazen Bootcamp—as well as aggressively building brand through Brazen Media (e.g., social media, Discord, and our newsletter) and Brazen Events.
Basically, we are going to keep kicking ass.
The debut of major Brazen Events begins with the Brazen Summit in June 2022—an in-person conference for biofounders by biofounders here in sunny Los Angeles, CA. The speakers and moderators are leaders in the early-stage founder-led bio movement. At scale, Brazen Events will be an important source of revenue.
Brazen Capital, LLC was established in November 2021 to fuel investments in Brazen Fellows. It is a separate legal entity, but Brazen Bio Inc. is the lead General Partner and majority owner and will receive the lion-share of profits from Brazen Capital investments. In this way, we can fuel our own future growth through our successes in supporting biotech founders.
We recently announced—to reward our earliest supporters—we are gifting all 189 of our 2021 Wefunder investors with carry (future profits) from Brazen Capital! We love the Brazen Army!
We've accomplished a lot in less than a year and it is just the beginning.
Ultimately, we intend to establish the "Harvard" of biotech... a vertically-integrated entity in Los Angeles—The Brazen Institute—in order to provide full-service support and resources to biotech founders from all over the world under one roof. This will include in-house capability for phase 1-scale manufacturing and early clinical trials.
Our vision is to help founders launch HUNDREDS of new biotech companies and technologies to benefit humanity and create massive value. JOIN US!
IMPORTANT: this Wefunder investment is in Brazen Bio Inc., a Delaware C corp. This is NOT an investment in Brazen Capital, LLC; Brazen Capital Fund I, LP; Brazen Capital Fund I GP, LLC; or companies resulting from the Brazen Fellowship (or other Brazen programs). If you are an accredited investor and interested in investing in the first Brazen Capital fund, please inquire HERE.